跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection - TGA Drug Approval Details
Approvals
/
TGA
/
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection
Approved
STANDARD
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection
Camurus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
45f38cf3615c310d
Company
Camurus Pty Ltd
Type
Standard
Approval Details
Approval Id
45f38cf3615c310d
Product Name
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection
Artg Id
295048
Artg Name
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection
Sponsor
Camurus Pty Ltd
Company Detail Path
/organization/camurus-pty-ltd
Artg Date
2018-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-02827-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02825-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
45f38cf3615c310d
Type
Standard
Back to TGA Approvals